Medical Data Vision Co., Ltd.

3902.T
Health Information Services
2026/02/16 Updated
Market Cap: $415.9M (¥63.6B)
Stock Price: $10.99 (¥1,680)
Exchange Rate: 1 USD = ¥152.91

(Correction) Notice Regarding Correction of Tender Offer Commencement Announcement Due to Submission of Correction to Tender Offer Notification by Nippon Life Insurance Company

Nippon Life Insurance Company submitted a correction to the tender offer notification for shares of Medical Data Vision Co., Ltd. to the Kanto Local Finance Bureau Director on January 19, 2026, and made partial corrections to the tender offer commencement announcement.

Importance:
Page Updated: January 19, 2026
IR Disclosure Date: January 19, 2026

Key Figures

  • Date of Submission of Correction to Tender Offer Notification: 2026年1月19日
  • Tender Offer Commencement Date: 2025年12月16日
  • Fair Trade Commission Approval Date: 2026年1月8日
  • Financial Services Agency Commissioner Approval Date: 2026年1月15日

AI要約

Regarding the Correction to the Tender Offer Notification

Nippon Life Insurance Company submitted the tender offer notification for shares of Medical Data Vision Co., Ltd. to the Kanto Local Finance Bureau Director on December 16, 2025, and commenced the tender offer. Upon obtaining approvals from the Fair Trade Commission and the Financial Services Agency Commissioner, corrections were made to some details in the tender offer notification and the tender offer commencement announcement. Therefore, on January 19, 2026, a correction notification was submitted, and part of the announcement was corrected.

Summary and Impact of the Correction

The correction concerns partial amendments to the conditions for withdrawal of the tender offer and does not constitute a change to the offer conditions. Specifically, the description of withdrawal conditions in cases where approvals by the Fair Trade Commission or the Financial Services Agency Commissioner are revoked or withdrawn has been simplified. This correction does not affect the execution of the tender offer and serves to enhance transparency for investors.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.